CH EMED (R4)
4.0.1 - trial-use Switzerland flag

This page is part of the CH EMED (R4) (v4.0.1: STU 4) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

ValueSet: ActSubstanceAdminSubstitutionCode

Official URL: http://fhir.ch/ig/ch-emed/ValueSet/ActSubstanceAdminSubstitutionCode Version: 4.0.1
Active as of 2023-12-28 Computable Name: ActSubstanceAdminSubstitutionCode

Copyright/Legal: CC0-1.0

ActSubstanceAdminSubstitutionCode

References

Logical Definition (CLD)

This value set includes codes based on the following rules:

This value set excludes codes based on the following rules:

 

Expansion

Expansion based on codesystem Substance Admin Substitution v3.0.0 (CodeSystem)

This value set contains 8 concepts

CodeSystemDisplayDefinition
  Ehttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutionequivalent

Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.

  EChttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutionequivalent composition

Description:

Substitution occurred or is permitted with another product that is a:

  • pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
  • pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration

Examples:

  • Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
  • Pharmaceutical equivalent: Lisonpril for Zestril
  BChttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutionbrand composition

Description:

Substitution occurred or is permitted between equivalent Brands but not Generics

Examples:

  • Zestril for Prinivil
  • Coumadin for Jantoven
  Ghttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutiongeneric composition

Description: Substitution occurred or is permitted between equivalent Generics but not Brands

Examples:

  • Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
  TEhttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutiontherapeutic alternative

Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.

Examples:

  • ranitidine for Tagamet
  TBhttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutiontherapeutic brand

Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics

Examples:

  • Zantac for Tagamet
  TGhttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutiontherapeutic generic

Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands

Examples:

  • Ranitidine for cimetidine
  Fhttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutionformulary

Description: This substitution was performed or is permitted based on formulary guidelines.

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code